DUPIXENT CUTANEOUS T-CELL LYMPHOMA LAWSUITS

Overview of Dupixent

Dupixent, a medication made by the companies Regeneron Pharmaceuticals and Sanofi Genzyme, is commonly prescribed to treat moderate to severe atopic dermatitis (AD) (a form of eczema), Chronic Obstructive Pulmonary Disease (COPD), asthma, and other illnesses. Unfortunately, recent studies show that dupilumab, the active ingredient in Dupixent, is tied to increased risk of Cutaneous T-Cell Lymphoma (CTCL) and its various subtypes, including but not limited to:

• Mycosis Fungoides
• Sézary Syndrome
• Lymphomatoid Papulosis
• Primary Cutaneous Anaplastic Large Lymphoma
• Subcutaneous Panniculitis-like T-Cell Lymphoma
• Extranodal NK/T-Cell Lymphoma
• Primary Cutaneous Gamma/Delta T-Cell Lymphoma.

Dupixent was granted priority approval by the FDA in 2017, which allowed the drug to be available to the public more quickly than usual. Since then, it has been widely prescribed for to treat a number of health issues.

Recent studies have found that long-term use of dupilumab can cause increased rates of CTCL.

A 2024 study published in the Journal of the American Academy of Dermatology established that the use of dupilumab to treat AD led to an increased risk of CTCL following treatment.

Studies in 2020 and 2021 also found that the use of dupilumab led to worsening of CTCL in patients already suffering from CTCL.

If you or a loved one has been diagnosed with CTCL after taking Dupixent, please call our team for a free consultation. We will shed light on the situation and help secure justice for you.

Criteria for Filing a Dupixent Lawsuit

At Levy Konigsberg, we are investigating claims on behalf of individuals who developed CTCL or other serious illnesses after using Dupixent You may qualify if you meet the following criteria:

• You took Dupixent for a period of at least one month.
• You were diagnosed with Cutaneous T-Cell Lymphoma (CTCL) or one of its subtypes. If you were diagnosed with a lymphoma but don’t know whether it is a CTCL subtype, we are available to discuss your options.

If you or a loved one has been affected, you may be entitled to compensation for medical expenses, lost wages, pain and suffering, and other damages.

Why Choose Levy Konigsberg?

• Experience: With decades of experience in complex litigation, our attorneys are well-equipped to handle product liability lawsuits.
• Results: We have recovered billions of dollars on behalf of our clients in mass tort and product liability cases.
• Personalized Attention: Each case is unique, and we provide personalized legal strategies tailored to our clients’ needs.

There are time limits for filing claims, so don't wait to seek legal advice.

Take the First Step Toward Justice

If you’ve been diagnosed with CTCL after using Dupixent, it’s time to take action. The road ahead may seem daunting, but you don’t have to face it alone. Levy Konigsberg’s experienced team is here to listen to your story, answer your questions, and help you pursue the justice you deserve.

Contact us today for a free consultation. Together, we can hold those responsible accountable and secure the compensation that will help you move forward with your life.